Search images on Google      Product Monograph

Active Ingredients:

• ranibizumab, 10 MG/ML

DIN: 02542250

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVITREAL

Description: SINGLE USE VIAL

Schedule: Prescription

Company: TEVA CANADA LIMITED  –  official site

ATC:

• S01 - OPHTHALMOLOGICALS (ATC, WHO, Wiki)
• S01L - OCULAR VASCULAR DISORDER AGENTS (ATC, WHO)
• S01LA - Antineovascularisation agents (ATC, WHO)
• S01LA04 - RANIBIZUMAB (WHO)

Reference brand drug: Lucentis

 

External Links for Ranopto:

Search on Google

• Ranopto side effects
• Ranopto dosage
• ranibizumab side effects
• ranibizumab dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find ranopto photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.